Back to search
FDAFDA · Food and drugs·Recall number D-1317-2020

Carbamazepine Tablets, USP 200 mg, packaged in a 500-count bottle, Rx only, Manufactured by: Torrent Pharmaceuticals Ltd, Bharuch 392130, India; Manufactured for: Torrent Pharma Inc., Basking Ridge, NJ 07920, NDC 13668-268-05

Published June 10, 2020 · Recall initiated: May 11, 2020

Summary

FDA records drug Class II recall D-1317-2020, published June 10, 2020 and initiated May 11, 2020. Recalling firm: Torrent Pharma Inc.; Status: Terminated; Reported quantity: 6228 Bottles; Lot: Lot #: 4FF4F001, Exp 1/2023. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Dissolution Specifications

What to do

Voluntary: Firm initiated · Letter

Get an email if CARBAMAZEPINE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
CARBAMAZEPINE
Manufacturer
Torrent Pharma Inc.
Distributor
USA Nationwide and Puerto Rico
Lot
Lot #: 4FF4F001, Exp 1/2023
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Carbamazepine Tablets, USP 200 mg, packaged in a 500-count bottle, Rx only, Manufactured by: Torrent Pharmaceuticals Ltd, Bharuch 392130, India; Manufactured for: Torrent Pharma Inc., Basking Ridge, NJ 07920, NDC 13668-268-05 recalled?

Yes. FDA published recall D-1317-2020 on June 10, 2020. Reported hazard: Failed Dissolution Specifications

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: CARBAMAZEPINE.